Posted On: 10/16/2015 12:47:32 AM
Post# of 72444
Re: daydreaming2 #14649
Exactly! I don't think Leo added the word by accident. He did the same when he added the word "p53-activating" before Kevetrin in this PR:
"BEVERLY, MA –May 28, 2013- Cellceutix Corporation (OTCBB: CTIX) (the “Company”), a clinical stage biopharmaceutical company focused on discovering small molecule drugs to treat unmet medical conditions, including drug-resistant cancers and autoimmune diseases, announces today that it will be presenting a poster on the company’s p53-activating drug, Kevetrin, at the 2013 American Society of Clinical Oncology (“ASCO”) Annual Meeting being held in Chicago, Illinois from May 31 through June 4, 2013.
http://cellceutix.com/cellceutix-to-present-p...jdpQB.dpuf
Activating is present continuous tense and we all know that Leo wasn't misleading at that time. It has been almost 5 months since the B-OM trial started and the treatment cycle is 7 weeks + 4 more weeks for observations. As a sponsor, Leo receives a case report for each patient, even though the trial is double-blinded.
"BEVERLY, MA –May 28, 2013- Cellceutix Corporation (OTCBB: CTIX) (the “Company”), a clinical stage biopharmaceutical company focused on discovering small molecule drugs to treat unmet medical conditions, including drug-resistant cancers and autoimmune diseases, announces today that it will be presenting a poster on the company’s p53-activating drug, Kevetrin, at the 2013 American Society of Clinical Oncology (“ASCO”) Annual Meeting being held in Chicago, Illinois from May 31 through June 4, 2013.
http://cellceutix.com/cellceutix-to-present-p...jdpQB.dpuf
Activating is present continuous tense and we all know that Leo wasn't misleading at that time. It has been almost 5 months since the B-OM trial started and the treatment cycle is 7 weeks + 4 more weeks for observations. As a sponsor, Leo receives a case report for each patient, even though the trial is double-blinded.
Quote:
Doesn't sound like a word you use by accident.... and that is huge!
(0)
(0)
Scroll down for more posts ▼
